Mesothelioma Clinical Trials Overview > Mesothelioma Clinical Trial List
Combination Chemotherapy and Tamoxifen in Treating Patients With Solid Tumors
| Conditions: | Adrenocortical Carcinoma|Brain and Central Nervous System Tumors|Head and Neck Cancer|Liver Cancer|Malignant Mesothelioma|Pheochromocytoma|Sarcoma |
| Start Date: | May 1, 1994 |
| Phase: | Phase II |
| Status: | Completed |
| NCT ID: | NCT00002608 |
| Study Type: | Interventional |
| Intervention: | Drug: cisplatin|Drug: doxorubicin hydrochloride|Drug: tamoxifen citrate|Procedure: conventional surgery|Radiation: radiation therapy |
| Study Design: | Masking: Open Label|Primary Purpose: Treatment |
| Results: | No Results Available |
| Sponsors: | Ottawa Regional Cancer Centre |
| Ages: | Child|Adult |
| Enrollment: | 30 |
| Funded By: | Other |
| First Received: | November 1, 1999 |
| End Date: | |
| Last Updated: | February 6, 2009 |
| Last Verified: | May 1, 2005 |
Mesothelioma
Lawsuit Evaluation
Lawsuit Evaluation
